BLUE - bluebird bio, Inc.
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Valuation measures4
| Market cap (intra-day) | 376.70M |
| Enterprise value | 331.82M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 93.37 |
| Price/book (mrq) | 1.06 |
| Enterprise value/revenue | 82.28 |
| Enterprise value/EBITDA | -1.38 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.93 |
| 52-week change 3 | 21.81% |
| S&P500 52-week change 3 | 3.90% |
| 52-week high 3 | 8.5800 |
| 52-week low 3 | 2.7800 |
| 50-day moving average 3 | 3.7278 |
| 200-day moving average 3 | 5.7873 |
Share statistics
| Avg vol (3-month) 3 | 4.81M |
| Avg vol (10-day) 3 | 3.24M |
| Shares outstanding 5 | 106.41M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 89.86M |
| % held by insiders 1 | 1.04% |
| % held by institutions 1 | 70.26% |
| Shares short (14 May 2023) 4 | 23.49M |
| Short ratio (14 May 2023) 4 | 5.32 |
| Short % of float (14 May 2023) 4 | 24.94% |
| Short % of shares outstanding (14 May 2023) 4 | 22.07% |
| Shares short (prior month 13 Apr 2023) 4 | 23.74M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1544:1000 |
| Last split date 3 | 04 Nov 2021 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 30 Mar 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -3,802.85% |
Management effectiveness
| Return on assets (ttm) | -16.19% |
| Return on equity (ttm) | -39.87% |
Income statement
| Revenue (ttm) | 4.03M |
| Revenue per share (ttm) | 0.05 |
| Quarterly revenue growth (yoy) | 22.40% |
| Gross profit (ttm) | -247.24M |
| EBITDA | -148.3M |
| Net income avi to common (ttm) | -123.19M |
| Diluted EPS (ttm) | -1.6300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 318.26M |
| Total cash per share (mrq) | 2.99 |
| Total debt (mrq) | 273.38M |
| Total debt/equity (mrq) | 77.06 |
| Current ratio (mrq) | 3.03 |
| Book value per share (mrq) | 3.34 |
Cash flow statement
| Operating cash flow (ttm) | -314.3M |
| Levered free cash flow (ttm) | -118.39M |
© 2023 Yahoo. All rights reserved.